Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wai-Kay Seto

Showing results (161-170 of 326) with videos related to

Pageof 33
Sort By:
Hepatology (Baltimore, Md.)|March 14, 2018
Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearanceJames Fung, Ka-Shing Cheung, Danny Ka-Ho Wong, et al.
Journal of Hepatology|June 25, 2013
Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatmentWai-Kay Seto, Kevin Liu, Danny Ka-Ho Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2022
Effect of Antiviral Treatment on Hepatitis B Virus Integration and Hepatocyte Clonal ExpansionNing Chow, Danny Wong, Ching-Lung Lai, et al.
The American Journal of Gastroenterology|May 5, 2011
Ketamine-induced cholangiopathy: a case reportWai-Kay Seto, Matthew Ng, Pierre Chan, et al.
Journal of Gastroenterology|October 9, 2015
Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durabilityWai-Kay Seto, Ka-Shing Cheung, Danny Ka-Ho Wong, et al.
Journal of Clinical Gastroenterology|October 30, 2020
Phenotypic Changes of PD-1 and GITR in T Cells Are Associated With Hepatitis B Surface Antigen SeroclearanceFen Liu, Saisai Zhang, Danny Ka-Ho Wong, et al.
Journal of Gastroenterology and Hepatology|April 3, 2022
Magnetic resonance imaging metrics and the predictability of adverse outcomes in on-treatment Asian chronic hepatitis BRex Wan-Hin Hui, Keith Wan-Hang Chiu, Lung Yi Mak, et al.
Oncology Letters|April 14, 2016
Interleukin-1β increases the risk of gastric cancer through induction of aberrant DNA methylation in a mouse modelFung-Yu Huang, Annie On-On Chan, Asif Rashid, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 24, 2016
Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosisDesmond Y H Yap, Wai Kay Seto, James Fung, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: outcome at 2 YearsJames Fung, Ching-Lung Lai, John Yuen, et al.
Pageof 33

Showing results (161-170 of 326) with videos related to

Sort By:
Pageof 33
Hepatology (Baltimore, Md.)|March 14, 2018
Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearanceJames Fung, Ka-Shing Cheung, Danny Ka-Ho Wong, et al.
Journal of Hepatology|June 25, 2013
Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatmentWai-Kay Seto, Kevin Liu, Danny Ka-Ho Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2022
Effect of Antiviral Treatment on Hepatitis B Virus Integration and Hepatocyte Clonal ExpansionNing Chow, Danny Wong, Ching-Lung Lai, et al.
The American Journal of Gastroenterology|May 5, 2011
Ketamine-induced cholangiopathy: a case reportWai-Kay Seto, Matthew Ng, Pierre Chan, et al.
Journal of Gastroenterology|October 9, 2015
Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durabilityWai-Kay Seto, Ka-Shing Cheung, Danny Ka-Ho Wong, et al.
Journal of Clinical Gastroenterology|October 30, 2020
Phenotypic Changes of PD-1 and GITR in T Cells Are Associated With Hepatitis B Surface Antigen SeroclearanceFen Liu, Saisai Zhang, Danny Ka-Ho Wong, et al.
Journal of Gastroenterology and Hepatology|April 3, 2022
Magnetic resonance imaging metrics and the predictability of adverse outcomes in on-treatment Asian chronic hepatitis BRex Wan-Hin Hui, Keith Wan-Hang Chiu, Lung Yi Mak, et al.
Oncology Letters|April 14, 2016
Interleukin-1β increases the risk of gastric cancer through induction of aberrant DNA methylation in a mouse modelFung-Yu Huang, Annie On-On Chan, Asif Rashid, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 24, 2016
Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosisDesmond Y H Yap, Wai Kay Seto, James Fung, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: outcome at 2 YearsJames Fung, Ching-Lung Lai, John Yuen, et al.
Pageof 33